Nuwellis (FRA:22S1) Tariff Resilience Score: 5/10 (As of Jul. 12, 2026)


FRA:22S1 Nuwellis Inc FRA:22S1
19 GF Score
Price €6,554.73
! 3 Warning Signs
View Full Analysis

What is Nuwellis Tariff Resilience Score?

Nuwellis FRA:22S1 19 Tariff Resilience Score is 5 as of Jul. 12, 2026. GuruFocus rates FRA:22S1 with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 835 Medical Devices & Instruments companies, Nuwellis ranks better than 79.28% on this metric.

Nuwellis has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Nuwellis has Medical device company with potential exposure to tariffs on imported components. However, it can mitigate risks through alternative suppliers and has some pricing power in niche markets.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nuwellis might have Average Resilient.

Nuwellis  (FRA:22S1) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nuwellis Tariff Resilience Score Related Terms

FRA:22S1 vs ESMC, RBOT, NUMD: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Nuwellis's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuwellis Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Nuwellis's Tariff Resilience Score falls into.


FRA:22S1
19GF Score
Nuwellis Inc FRA:22S1
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Nuwellis (FRA:22S1) has a Tariff Resilience Score of 5 as of Jul. 12, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Nuwellis ranks #173 out of 835 companies in the Medical Devices & Instruments industry, placing it in the top 20.7%.
Is Nuwellis' Tariff Resilience Score too high?
Nuwellis' current Tariff Resilience Score is 5. Based on the distribution chart, Nuwellis ranks #173 out of 835 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nuwellis has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Nuwellis' Tariff Resilience Score compare to ESMC and RBOT?
According to the Medical Devices & Instruments industry distribution chart, Nuwellis ranks #173 out of 835 companies for Tariff Resilience Score. This places Nuwellis in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Nuwellis's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuwellis stock overvalued right now?
Nuwellis (FRA:22S1) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Nuwellis' overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Nuwellis (FRA:22S1), the current Tariff Resilience Score is 5 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuwellis Business Description

Other Exchanges NUWE:USA
Address 12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
19GF Score

Get the complete analysis for FRA:22S1

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6,554.73
Price